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Introduction
The recent developments of imaging tech-
niques and transfection methodologies applic-
able to differentiated, non-dividing cells, such
as neurons, has opened new avenues to inves-
tigate the role of specific genes and proteins
in complex physiological or developmental
mechanisms. Furthermore, by combining the
expression of several fluorescently tagged mol-
ecules or peptides capable of interacting with
each other, it has become possible to design
rescue-type experiments and thus investigate
the role of signaling pathways in the gen-
eration of specific phenotypes. These new ap-
proaches, mainly applied so far to dissociated
cell cultures, have not only brought comple-
Molecular Neurobiology 67 Volume 34, 2006
Molecular Neurobiology
Copyright © 2006 Humana Press Inc.
All rights of any nature whatsoever reserved.
ISSN 0893–7648/06/34(1): 067–080/$30.00
ISSN (Online) 1559–1182
Central Nervous System Functions of PAK Protein Family
From Spine Morphogenesis to Mental Retardation
Bernadett Boda, Irina Nikonenko, Stefano Alberi, 
and Dominique Muller*
Department of Neuroscience, Centre Médical Universitaire, 1211 Geneva 4, Switzerland
Abstract
Several of the genes currently known to be associated, when mutated, with mental retardation,
code for molecules directly involved in Rho guanosine triphosphatase (GTPase) signaling. These
include PAK3, a member of the PAK protein kinase family, which are important effectors of small
GTPases. In many systems, PAK kinases play crucial roles regulating complex mechanisms such
as cell migration, differentiation, or survival. Their precise functions in the central nervous system
remain, however, unclear. Although their activity does not seem to be required for normal brain
development, several recent studies point to a possible involvement in more subtle mechanisms
such as neurite outgrowth, spine morphogenesis or synapse formation, and plasticity. This article
reviews this information in the light of the current knowledge available on the molecular charac-
teristics of the different members of this family and discuss the mechanisms through which they
might contribute to cognitive functions.
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mentary information to that traditionally
obtained through studies of transgenic ani-
mals, but they have also speeded up and
markedly increased the capacity of analysis.
One domain in which these new technologies
have revealed particularly interesting informa-
tion is the study of the complex signaling cas-
cades contributing to synapse development and
plasticity, particularly those involving a partici-
pation of the family of small Rho guanosine
triphosphatases (GTPases). These molecules
function as molecular switches integrating
extra- and intracellular signals to control actin
rearrangement (1). Through their critical impli-
cation in the complex control of cytoskeleton
dynamics, members of the Rho GTPase family
revealed crucial for many important aspects of
neuronal plasticity including cell migration,
axonal growth, protrusion and filopodia elon-
gation, formation of dendritic spines and estab-
lishment of synaptic contacts. Consistent with
these key functions, recent genetic studies have
revealed that several members of these signal-
ing cascades are associated, when mutated in
humans, with cognitive defects and mental
retardation (2). These observations have raised
the possibility that an important cause for men-
tal retardation or diseases such as autism or Rett
syndrome might include developmental abnor-
malities in the formation and function of synap-
tic networks. Therefore, there is an important
need for a better understanding of the molecu-
lar events that participate in these regulations,
particularly at the level of synapses. 
The possible number of interacting genes
and proteins involved in Rho GTPases signal-
ing is particularly high and the complexity of
their interactions still poorly understood.
Among these numerous molecular partners,
the PAK protein family is of particular interest
as members of this family probably represent
important effectors of Rho GTPase activation,
mediating, or participating in some of the key
aspects of plasticity described so far (3). PAK3
is indeed one of the Rho GTPases-associated X-
linked gene for which several mutations have
been reported in humans to result in non-syn-
dromic mental retardation (i.e., cases of the
disease in which the only defect is a mental
handicap; refs. 2, 4, 5, and 6). This article
reviews some of the key molecular features of
this protein family, focusing primarily on the
possible functional implications of the differ-
ent members of the family with regard to
synapse development and formation.
Structure of Pak Proteins 
and Mechanisms of Activation
PAKs are a highly conserved family of ser-
ine/threonine protein kinases (7). They were
first identified in a screen for binding partners
of the protein p21, a member of the Rho family
of small GTPases (8). A main feature of Rho
GTPases is the ability to cycle between guano-
sine triphosphate (GTP)- and guanosine
diphosphate (GDP)-bound forms, where the
GTP-bound form is the activated state and the
only one capable of interaction with down-
stream effectors. Hydrolysis of the GTP by their
intrinsic GTPase activity returns them to the
inactive stage. The regulation of small GTPase
activity is a complex phenomenon involving
the participation of a large variety of regulators.
Guanine exchange factors (GEFs) activate
GTPases by mediating the exchange of GDP for
GTP (9). GTPase-activating proteins inactivate
them by stimulating the intrinsic GTPase activ-
ity of these molecules (10). The activity of
GTPases is further regulated by guanine disso-
ciation inhibitors (GDIs), which bind to GDP-
bound form and inhibit the dissociation of
GDP. However, GDIs also contribute to extract
the GTPase from the membrane and sequester
it in the cytosol. Membrane association of
GTPases is thus believed to represent an impor-
tant aspect contributing to the regulation of
their activity and function and GDIs probably
play a dual role by regulating both the
GDP/GTP cycling and the membrane associa-
tion/dissociation characteristics (11). Activated
GTPases then bind to various downstream
effectors, among which is the PAK protein fam-
ily. The two main GTPases that usually interact
with and activate PAKs are Cdc42 and Rac1. 
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All PAKs contain a regulatory N-terminal
p21 GTPase-binding domain (PBD), which
includes a more restricted binding region for
Cdc42 and Rac1 referred to as the Cdc42 and
Rac interactive binding (CRIB) domain, as well
as a highly conserved C-terminal protein
kinase domain. In worms, flies, and mammals,
PAKs fall into two distinct groups based on
sequence conservation and organization of
domains. In mammals, group A comprises
PAK1 (αPAK), PAK2 (γPAK), and PAK3 (βPAK),
while group B consists of PAK4, PAK5, PAK6
(7). Figure 1 shows the protein structure of
PAKs.
Group A PAKs contain an N-terminal regu-
latory domain whose distinguishing feature is
the presence of proline-rich motifs that medi-
ate associations with various proteins contain-
ing Src-homology 3 (SH3)-domains. There are
five (PAK1), two (PAK2), or four (PAK3)
canonical PXXP SH3-binding motifs for
adapter protein interactions and one non-clas-
sical (PXP) SH3-binding site for the PIX family
of proteins. Another interesting part of the reg-
ulatory region is the autoinhibitory domain
that is flanking the CRIB or PBD region. This
domain binds to and negatively regulates the
catalytic site. It functions as an inhibitory
switch that controls the kinase basal activity.
Group A PAKs further contain an acidic
residue-rich region of unknown significance,
as well as a conserved binding site for the βγ-
subunit complex of G proteins (1). Recent data
indicate that a Gβγ–PAK1 interaction is in-
volved both as a scaffold protein for Cdc42
activation and as an effector of Cdc42 in medi-
ating directional migration of chemotactic leu-
cocytes (12). 
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Fig. 1. Molecular structure of human PAK proteins. SH3, proline-rich regions; PBD, p21-binding domain;
CRIB, Cdc42 and Rac interactive binding; AI, autoinhibitory domain; Pix, Pix-binding site. The gray squares
show the localization of the three mutations identified in human cases of mental retardation.
All group A PAKs bind Cdc42 and Rac and
are strongly activated upon binding these
GTPases. However, they can also be activated
by a variety of other GTPase-independent
mechanisms (1). For example, PAK1 has been
shown to be directly activated by Akt, a proto-
oncogen kinase (13), and this mechanism has
been proposed to account for cell survival
action of PAK1 (14).
Based on what has been found for PAK1, it is
believed that group A PAKs form homodimers
in solution and in cells. In this configuration,
the N-terminal regulatory domain of one PAK1
molecule binds and inhibits the C-terminal cat-
alytic domain of the other. In this way, dimer-
ization allows overlap of the PBD/CRIB and
inhibitory switch domains (15,16), thus main-
taining the kinase inactive. Activation of the
enzyme is then believed to involve GTPase
binding, which disrupts dimerization and
leads to a series of conformational changes that
destabilize the folded structure of the inhib-
itory switch domain. This induces its dissocia-
tion from the catalytic domain resulting in
kinase activation.
Group B PAKs show important similarities
with group A PAKs. They also contain a PBD
region at the extreme N-terminus of the pro-
tein followed by a C-terminal kinase domain
(17). This group binds Cdc42 and to a lesser
extent Rac1, but, unlike group A PAKs, bind-
ing does not lead to a consistent activation of
the kinase. Rather, it would seem that associa-
tion with Cdc42 contributes to regulate the
localization of group B kinases and not their
activation per se (7). However, the precise
mechanisms involved in group B PAKs acti-
vation remain unclear. 
Signaling Through PAKs
PAKs are believed to produce most of their
effects through their activity of serine/threo-
nine phosphorylation. They have been impli-
cated in a broad range of biological functions,
including cell migration and motility, actin
reorganization, gene transcription, cell prolif-
eration, and cell survival. Their substrates are
diverse and numerous, affecting the signaling
of various pathways.
In mammals, as in simpler eukaryotes, PAKs
play an important role by regulating mitogen-
activated protein kinase cascade. They appear
to do this through the phosphorylation of Raf1
and Mek1 (18,19), a step that is required for the
activation of these two molecules and the sub-
sequent stimulation of transcription that they
regulate. However, there is also recent evidence
that PAK1 may directly associate with Erk1/2,
allowing the recruitment of Raf1, Mek1, and
Erk1/2 to adhesion complexes (20). It is proba-
bly through activation of this pathway that
PAK1 contributes to its mitogenic activity and
participates in the regulation of cell prolifera-
tion or differentiation. Several lines of evidence
also suggest that integrins and growth factors
might promote Erk signaling through an acti-
vation of Rac and PAKs, in this way mediating
adhesion-dependent processes, such as migra-
tion and motility (20–23).
Another group of mechanisms in which
PAKs appear to be involved is the control of the
cytoskeleton and the regulation of actin dynam-
ics. The pathways through which PAKs partici-
pate in these processes also appear to be diverse
and remain poorly understood. In many cases,
activation of PAKs results from signaling medi-
ated through either adhesion molecules or
growth factors (21,24–26). PAKs then probably
act through different pathways. One possibility
involves the activation of LIM-kinase (LIMK),
which in turn could phosphorylate cofilin and
thus control actin rearrangement (27–29). PAK1
can, however, also activate myosin light chain
kinase (MLCK), involved in myosin–actin
interactions (30), or directly regulate micro-
tubule-associated proteins and affect micro-
tubule dynamics (31). Furthermore, PAKs may
additionally interact with or activate various
exchange factors that may feed back on Rac1
activity or mediate coordination with other
GTPase signaling pathways (32–34). Overall,
the role of PAKs in regulating cytoskeleton
dynamics is believed to be important for PAKs
functions in the brain.
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Role of PAKs in Invertebrates 
PAKs homologs exist in invertebrates and
several models have provided interesting
information about their neuronal implication.
Drosophila encodes one group A PAK, DPAK1;
one group B, referred to as mushroom bodies
tiny (Mbt); and a third group that does not fit
easily into either classification, DPAK3 (7). The
functions of DPAK1 and Mbt, but not DPAK3,
have been analyzed by genetic techniques.
Loss-of-function mutation in DPAK1 indicates
a role for the protein in axon guidance (35–37)
and the regulation of postsynaptic proteins
localization and structure at the glutamatergic
neuromuscular junctions (38). Mbt was uncov-
ered in a genetic screen for genes involved in
the formation of the mushroom body, a struc-
ture in the adult fly corresponding to the
human hippocampus and involved in learning
and memory. Mbt-null mutant have defects in
cell proliferation, differentiation, or survival of
the mushroom body neurons leading to a dra-
matic reduction of its volume (39). In addition,
Mbt mutants display defects of photoreceptor
morphogenesis (40). These data clearly indi-
cate an important role of PAK protein family in
brain development. 
In Aplysia, a mollusc widely used as a
model for studies of sensory learning, stimula-
tion of the siphon results in a gill-withdrawal
reflex that can be mapped to specific synaptic
connections between identified sensory and
motor neurons. Long-term sensitization or
facilitation of this reflex has been shown to be
associated with the growth of new sensory
neuron varicosities. Repeated applications of
serotonin reproduce the phenomenon. Recently,
it was found that serotonin-induced synaptic
growth requires the activation of several pro-
teins including ApCdc42, the Aplysia homolog
of Cdc42, neuronal Wiskott-Aldrich syndrome
protein (N-WASP) and PAK (41). They showed
that repeated serotonin administration acti-
vates ApCdc42, recruiting N-WASP and PAK,
thereby leading to the outgrowth of filopodia.
The PAK protein involved in these mecha-
nisms was recognized by a PAK1 antibody and
thus probably represents a mammalian PAK1
homolog. 
Role of PAK1 in Mammalian Central
Nervous System
PAK1 is expressed in the brain, muscle, and
spleen. However, its function has mainly been
studied in fibroblasts or other dissociated cell
lines (3,42). In these cells, PAK1 has been local-
ized to focal adhesion complexes, which medi-
ate signaling and contact with the extracellular
matrix (43). Activated PAK1 has been found to
induce polarized filopodia and membrane ruf-
fles (42). An important role of PAK1 has thus
been proposed in the regulation of cell motility
and migration. 
In rat brain, PAK1 has a high level of expres-
sion, as shown by in situ hybridization tech-
niques in cerebral cortex and piriform cortex,
ventral and lateral thalamic nuclei, CA1 of the
hippocampus, subiculum, cerebellum, and
medulla (8,44). So far, the major role reported
for PAK1 in neurons is in neurite formation
(33,45,46), although the data point also to a
possible role of PAK1 in modulating growth
cone behavior (47). In cortical primary neu-
rons, PAK1 was found to be responsible for
dendrite initiation (48) and, in hippocampal
primary neurons, overexpression of a GEF
(GEFT) inducing PAK1 and PAK5 activation
also resulted in neurite outgrowth (33,45).
Transfection studies carried out on dissociated
hippocampal neurons further revealed that
expression of constitutively active PAK1, but
also PAK3, promoted the formation of den-
dritic spines and protrusions, an effect that
was correlated by an increase in the number
of excitatory synapses (30). This phenotype
corresponded to that observed with Rac1 over-
expression and could be reproduced by activa-
tion of MLCK. Furthermore, they could link
this phenotype to the activation of two other
synaptic proteins, βPix, a GEF for Rac and
GIT1, its adaptor-binding partner. They found
that expression of a dominant-negative GIT1,
disrupting its synaptic localization, resulted in
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numerous dendritic protrusions and a signifi-
cant decrease in the number of synapses and
normal mushroom-shaped spines. Conversely,
knockdown of GIT1 by short interfering
RNA (siRNA) techniques caused a decrease in
spine and synaptic density. Furthermore, they
found that Rac1 is locally activated in den-
dritic spines and is regulated by βPIX. Taken
together, they proposed the interesting
hypothesis that a GIT1/βPIX/Rac/PAK1,3
signaling complex would regulate the mecha-
nisms of spine formation in hippocampal
neurons through activation of MLCK and
myosin/actin interactions.
Curiously, and in contrast to this finding,
genetic analyses of PAK1 functions revealed
that PAK1-null mice are viable and show no
detectable neuronal phenotype, except for
some immune defects (7). In another recent
approach, transgenic mice were generated that
expressed a dominant-negative PAK peptide
under the control of the α calcium-calmodulin-
dependent protein kinase II promoter, the
expression being thus limited to the forebrain
and post-developmental stages (48). This 68
amino acid peptide corresponded to the
autoinhibitory domain of PAKs, which binds
to the catalytic domain of all three PAKs of
group A family to block their autophosphory-
lation and consequently their activation. How-
ever, it is likely that PAK1 is the major
contributor to the phenotype of these mice, as
the level of PAK1 expression in the postsynap-
tic density fraction is much higher than that of
PAK2 and PAK3.
Interestingly, analyses of these mice showed
that there were no significant alterations in den-
drite formation, and no differences in dendritic
length or dendritic branch points. However,
cortical, but not hippocampal, neurons dis-
played fewer dendritic spines and an increased
proportion of larger spines compared with
wild-type controls. These alterations of cortical
synapse morphology were associated with
enhanced glutamate receptor-mediated synap-
tic transmission, enhanced long-term potentia-
tion (LTP), but reduced long-term depression.
These mice also exhibited specific deficits in the
consolidation phase of hippocampus-depen-
dent memory, although the level of phosphory-
lated PAK activity (PAK1/2/3) was high in this
structure and there were no other morphologi-
cal or functional hippocampal defects. A possi-
ble explanation for these puzzling observations
is that a 40% reduction in overall PAK levels is
possibly not sufficient in the hippocampus to
result in a phenotype or, alternatively, that the
suppression of PAK under the control of the
α calcium-calmodulin-dependent protein kin-
ase II promoter occurred too late to generate
defects. There might also be compensation
mechanisms activated in transgenic mice mod-
els that are more easily avoided upon transient
transfection.
Together and despite some inconsistencies,
our current knowledge of the role of PAK1 in
the brain suggests that the kinase is probably
an important molecule for the morphogenesis
of dendritic spines and the development of
synaptic networks. 
Role of PAK3 in Mammalian 
Central Nervous System
As a result of its involvement in mental
retardation in humans, PAK3 is clearly one of
the interesting members of the PAK protein
family. It is so far the only PAK protein associ-
ated with mental retardation and its mutation
results in a non-syndromic form of the disease,
in which the mental handicap is the unique
clinical manifestation. It is also interesting that
the human genes encoding the six isoforms are
situated on six different chromosomes: five of
them are on the somatic chromosomes (PAK1:
chrom. 11, PAK2: chrom. 3, PAK4: chrom. 19,
PAK5: chrom. 20, and PAK6: chrom. 15) and
one, PAK3, is on the chromosome X. Three
types of point mutations have been described
for PAK3: MRX30 is an R419-Stop mutation
that generates a truncated form of the PAK3
protein without kinase activity (5), MRX47 is a
R67C missense mutation near CRIB domain
(4), and, lastly there is an A365E missense
mutation that affects the kinase subdomain (6).
72 Boda et al.
Molecular Neurobiology Volume 34, 2006
The absence of severe brain defects in these
MRX patients suggests that PAK3 function is
not absolutely required for neuronal prolifera-
tion, migration, and/or cortical gyration.
However, the observation that PAK3 mutation
results in mental retardation might reflect a
later requirement for PAK3 function in the
developing or adult cortex for synapse devel-
opment and/or synaptic plasticity. Much
recent evidence indeed suggests that various
genetic forms of mental retardation could be
linked to abnormalities in the mechanisms that
regulate dendritic spine morphogenesis or
synapse formation (49,50).
Dendritic spines are specialized morpholog-
ical structures that host excitatory synapses in
the central nervous system of mammals. These
small protrusions are actin-rich, highly motile,
and share different sizes and forms (51,52).
Dendritic spine morphology and function are
tightly associated. Dendritic spines show very
dynamic properties; they undergo a turnover
that is developmentally regulated and modu-
lated by activity and express properties of plas-
ticity both in terms of function and structural
organization. It is believed that these proper-
ties of plasticity underlie some of the higher
cognitive functions, such as learning and
memory (53–55). An involvement of mental
retardation proteins in these mechanisms
could therefore provide a plausible phys-
iopathological explanation of the disease. 
PAK3 is reported to be a brain-specific iso-
form, although it is also expressed in the testis
(5,56). It is interesting that genes, expressed
simultaneously in the brain and testis, have
been proposed to be relevant for human speci-
ation (57). In the adult rat brain, PAK3 is
expressed at high levels in the piriform cortex,
medial preoptic nucleus, hippocampus, amyg-
dala, hypothalamus, thalamus, and dorsal
raphe nucleus (8,56). 
Experimental data on the role of PAK3 in
PC12 cells showed that overexpression of
PAK3 induced cell spreading, membrane ruf-
fling, and increased lamellipodia formation at
growth cones and shafts of neurites, an effect
mediated through interaction with βPIX (58).
Transfection of dissociated hippocampal neu-
rones with constitutively active PAK3 resulted,
as for PAK1, in an increase in dendritic protru-
sions and increased spine density, while con-
versely, expression of kinase-dead mutants
decreased spine density and PSD-95 clusters.
The role of PAK3 in hippocampus was further
analyzed in hippocampal slice cultures, an in
vitro model that is more closely related to in
vivo networks. In this study, we found that
PAK3 significantly contributes to synapse for-
mation and plasticity (59). Pyramidal neurones
within organotypic slice culture were trans-
fected with different PAK3 contructs using a
biolistic approach. The results showed that
overexpression of wild-type PAK3 did not
affect spine morphology, whereas interference
with PAK3 function, either through expression
of a PAK3 construct carrying the human
MRX30 mutation, through knockdown of the
protein by antisense or siRNA approaches,
resulted in the formation of abnormally elon-
gated dendritic spines and filopodia-like
protrusions and a decrease in mature, mush-
room-type spines, thus reproducing the phe-
notype described in human cases of mental
retardation (Fig. 2A; ref. 60). Closer analysis at
the electron microscopy level of these modified
protrusions revealed that many of them (up to
30%) failed to contact presynaptic terminals
(Fig. 2B). Furthermore, those spines that
formed synaptic contacts expressed postsy-
naptic densities of reduced size, as measured
on electron microscopy sections. These abnor-
malities were further associated with a
reduced spontaneous activity, altered expres-
sion of AMPA-type glutamate receptors, and
defective LTP (Fig. 2C,D). Together, this study
showed that transient suppression of PAK3 in
pyramidal neurons resulted in an increased
proportion of immature, non-functional spines,
a defect in establishment of synaptic contact,
and stabilization of the postsynaptic density as
well as altered properties of synaptic plasticity.
As such, these alterations are likely to pro-
foundly affect information processing by these
neurons and could provide a mechanism
explaining the cognitive handicap. Somewhat
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in contrast with these data, a very recent study
of PAK3 knockout mice showed defects in
long-lasting synaptic plasticity and impaired
learning of a taste aversion associative task,
but, surprisingly, no detectable spine abnor-
malities and no deficit in hippocampus-depen-
dent spatial memory (61). An interesting
finding, however, was that these PAK3 knock-
out mice exhibited defects in the regulation of
cyclic adeonsine monophosphate-responsive
element-binding (CREB) function, suggesting
a possible novel mechanism through which
PAK3 might affect synaptic plasticity. 
Another interesting aspect of PAK3 function
has also been illustrated recently in the context
of Alzheimer’s disease. It was found that PAK3
binds the amyloid precursor protein (APP) on a
site adjacent to the CRIB domain and that it par-
ticipates in this way in APP-mediated apoptosis
and DNA synthesis (62). This mechanism is
probably the result of a miss-regulation between
mutant APP and PAK3. Binding of APP to PAK3
may draw it into a complex of proteins, or move
it into a compartment of the cell where it might
be exposed to new substrates, illustrating the
importance not only of the mechanisms of PAK3
activation, but probably also of the localization
of this activity. Together these data about PAK3,
and also PAK1, it is suggested that these two
kinases are important modulators of synapse
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Fig. 2. Spine and synaptic defects associated with expression of PAK3 carrying the human MRX30 mutation.
(A) Illustration of the alterations in spine morphology observed with confocal microscopy in CA1 pyramidal
cells transfected with EGFP (ctrl) or PAK3 carrying the MRX30 mutation (MRX30) or PAK3 siRNA oligos. Note
the increased number of filopodia-like, elongated spines and the reduction in mushroom-type spines. Scale bars:
2 μm. (B) Electron microscopy three-dimensional reconstructions of dendritic spines in cells transfected with
EGFP (Ctrl) or PAK3 carrying the MRX30 mutation (MRX30). Many of filopodia-like, elongated spines failed to
establish synaptic contacts and when this occurred, the postsynaptic density was smaller. Scale bars: 0.5 μm. (C)
Cells transfected with PAK3 carrying the MRX30 mutation showed reduced AMPA/N-methyl-D-aspartate recep-
tor ratios, suggesting the presence of immature spines. (D) Cells transfected with PAK3 failed to express long-
term potentiation (filled circles) in contrast to what was observed in control cells (open circles).
formation and plasticity mechanisms. However,
it remains unclear up to which point PAK3 and
PAK1 have specific and/or different roles and
how exactly they produce these effects.
Central Nervous System Functions 
of Other PAK Proteins
PAK2 is a ubiquitously expressed member of
group A family of PAKs. It has the characteris-
tic of being activated through proteolytic
cleavage by caspases or caspase-like proteases.
Full-length PAK2 is localized in the cytoplasm
and stimulates cell survival, while the prote-
olytic fragment (PAK2p34) obtained by cleav-
age translocates to the nucleus and is involved
in the cell death response of non-neuronal cell
lines (63). PAK2 also contributes to the patho-
genicity of the human immunodeficiency virus
infection (64). PAK2 knockout mice are not
viable (7) and the only information available
about PAK2 in neurons concerns its involve-
ment in a signaling pathway for basic fibrob-
last growth factor. In PC12 cells, it was found
that activation of a PAK2/βPIX complex via
the ERK cascade induced neurite outgrowth
(65). Effects on spine morphogenesis were not
yet reported for PAK2.
PAK4 was the first described group B family
isotype. It was identified from a polymerase
chain reaction screen with degenerate primers
based on the PAK2 kinase domain. It is impli-
cated in actin cytoskeleton reorganization and in
the formation of filopodia in different cell lines
(66). These cytoskeletal changes are mediated by
LIMK1 and cofilin (67). PAK4 also participates
in cell death signaling, cell growth, and migra-
tion (68,69). It was found to be expressed in
most tissues examined, with the highest levels
in the prostate, testis, and colon, but abundant
in all tumor cell lines analyzed (66,68). Mouse
PAK4-null embryos die at an early embryonic
stage (E10.5) by an unknown mechanism (70).
They display cardiac and neuronal defects. Neu-
ronal progenitors form normally, but differentia-
tion of these cells is mostly inhibited, axonal
outgrowth is impaired, and neurons do not
migrate to their correct target area. A synapse-
specific role of PAK4 was not studied yet.
PAK5 is the brain-specific member of the
group B PAKs. First it was described in Xenopus
to act on microtubule stabilization, then it was
cloned from human testis and brain, and
demonstrated to promote neurite outgrowth in
N1E-115 cells (71–73). PAK5 is also thought to
have a role in the regulation of apoptosis (74).
PAK5 knockout mice develop normally, they are
fertile and no phenotype was found until now
(75). It seems that, in vivo, PAK5 is not impli-
cated in brain development, but it could partici-
pate in more subtle neuron-specific functions.
PAK6 was discovered in a yeast two-hybrid
screen for androgen receptor-interacting pro-
teins (76). It is mainly expressed in brain, testis,
prostate, and breast tissues, and specifically
represses androgen and estrogen receptor-
mediated transcriptions (77). Specific functions
in the brain have not yet been reported.
Conclusion
PAK proteins form a family of kinases that
are highly implicated in several important
processes in mammalian tissue. As reported
earlier, the neuronal functions of these kinases
remain unclear for most of them, although
recent data point to a clear implication of PAK1
and PAK3 in the regulation of spine morpho-
genesis, synapse formation, and plasticity.
Whether the role of PAK1 and PAK3 in these
mechanisms is specific and how it differs from
that of the other members of the family is still
an intriguing question. One might wonder, for
instance, what is the significance of all these
different isoforms? It has been proposed that
evolution of higher complexity requires acqui-
sition of pleiotropy: the same genes are rede-
ployed to different functions within a network
of epistatic interactions (78). Thus the speci-
ficity of the different PAK proteins might not
be so much in the different functions to which
they participate and which indeed share simi-
larities, but in their localization and distribu-
tion in different cell types.
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In the brain, the information currently avail-
able mainly suggests an important role for
PAK1 and PAK3. In both cases, an implication
as effectors of Rac1 signaling appears the most
likely in view of the similarities in phenotype
observed when interfering with Rac1 (79)
and/or PAKs: the main defects concern spine
formation mechanisms and spine morphology.
However, how the signaling cascade is initiated
remains unclear. Work by Penzes et al. (25) sug-
gests that activation of Ephrin receptors EphB2
may induce synaptic recruitment of the Rho-
GEF kalirin, resulting in local activation of Rac1
and PAKs. There is also evidence from other
cell types that integrin signaling may result in
activation of a Pix/Rac/PAK complex. Accord-
ingly, a possible working model that could
account for the effects of PAKs on spine mor-
phogenesis is summarized in Fig. 3. Intercellu-
lar signaling through adhesion molecules,
growth factors, or Ephrin receptors could lead
to GEFs activation, which could include kalirin
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Fig. 3. Hypothetical model to account for the role of PAK1 and PAK3 in spine morphogenesis and synaptic plas-
ticity. Communication between pre- and postsynaptic structures is required to establish a functional, mature synap-
tic contact. This communication could involve the participation of adhesion molecules (integrins, CAMS), growth
factors, or Ephrin receptors that would signal to guanine exchange factors molecules (kalirin, GIT1/Pix/PAK com-
plex) localized in spines and postsynaptic densities. These in turn might result in Rac1 activation, which, through
PAK activation and downstream effectors (LIM kinase, myosin light chain kinase), would regulate actin dynamics
and actin–myosin interactions. This reorganization of the cytoskeleton is known to be necessary for the establish-
ment of mature synaptic contacts and for properties of synaptic plasticity, such as long-term potentiation.
or a Git1/Pix/PAK complex. This would
recruit and activate Rac1 in spines and result in
PAK activation, which, in turn, would act on a
number of potential substrates (MLCK, LIMK,
mitogen-activated protein kinase cascade) reg-
ulating actin organization or actin–myosin
interaction. An interesting hypothesis would be
to consider that this signaling pathway would
be critically involved in the communication
between pre- and postsynaptic structures and
contribute to the formation and stabilization of
the postsynaptic density and eventually also in
its capacity for plasticity. Much recent evidence
has indeed shown that actin dynamics and
reorganization of the spine cytoskeleton are
required for the expression of properties of
synaptic plasticity, such as LTP (80). This attrac-
tive possibility is supported by several recent
studies and in particular the observation that
expression of PAK3 mutants is associated with
defects in synaptic contact formation and the
existence of immature postsynaptic densities.
There are, however, numerous questions that
remain unanswered, particularly with regard to
the molecular partners involved and the
numerous possibilities of interactions with
other signaling pathways. In particular, the
very recent evidence for abnormalities in CREB
phosphorylation obtained from mice lacking
PAK3 gene (61) raises the possibility that the
kinase contributes not only to cytoskeletal con-
trol, but also to more complex regulations,
including modulation of gene expression. In
view of the importance of PAK protein for the
understanding of the molecular events under-
lying cognitive mechanisms, it is very likely
that this new exciting field will progress
rapidly in the coming years and bring new
light on the complexity of the machinery that
controls synaptic structures.
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